Tran, Katie
Wang, Lu
Mehra, Reena
Vanek, Robon
Kaw, Shivani
Campean, Tina
Foldvary-Schaefer, Nancy
Moul, Douglas E.
Walia, Harneet
Article History
Received: 2 November 2020
Revised: 26 February 2021
Accepted: 15 March 2021
First Online: 29 April 2021
Declarations
:
: 1. Katie Tran, M.D—no financial disclosures, no conflicts of interests2. Lu Wang, M.S—no financial disclosures, no conflicts of interests3. Reena Mehra, M.D, M.S—her institution has received positive airway pressure machines and equipment from Philips Respironics for use in NIH-funded research. She has received honorarium from the American Academy of Sleep Medicine for speaking4. Robon Vanek, R.N, A.N.P—no financial disclosures, no conflicts of interests5. Shivani Kaw—no financial disclosures, no conflicts of interests6. Douglas E Moul, M.D., M.P.H.—no financial disclosures, no conflicts of interests7. Tina Campean, R.N—no financial disclosures, no conflicts of interests8. Nancy Foldvary-Schaefer, D.O, M.S—is a consultant for Jazz Pharmaceuticals9. Harneet Walia, M.D—has received funding from Resmed for randomized controlled trial to assess the impact of sleep apnea management clinic in PAP adherence. She is the principal investigator of the studies with hypoglossal nerve stimulator.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This was a retrospective study; informed consent was not obtained.
Free to read: This content has been made available to all.